Article
The Case Against Censoring of Progression-Free Survival in Cancer Clinical Trials – A Pandemic Shutdown as an Illustration
2021-12-30
Abstract excerpt
Missing data may lead to loss of statistical power and introduce bias in clinical trials. The ongoing Covid-19 pandemic has had a profound impact on patient health care and on the conduct of cancer clinical trials. Restricted access to sites, medication and evaluations brings challenges to the analysis of clinical trials due to missing data. Although several endpoints may be affected, progression-free survival (PF...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e8d63a22-fffa-51ef-adc6-04b68e9c2393
- DOI
- 10.21203/rs.3.rs-1033601/v1
